Drug Profile
KUR 211
Alternative Names: I-020201; KUR-211Latest Information Update: 21 Aug 2015
Price :
$50
*
At a glance
- Originator Kuros Biosurgery
- Developer Baxalta; Kuros Biosurgery
- Class Blood proteins; Growth factors; Peptides
- Mechanism of Action Platelet derived growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic foot ulcer